A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women

NCT01121640 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

854

Enrollment

OTHER

Sponsor class

Conditions

Epithelial Ovarian Cancer

Interventions

PROCEDURE: CA125 assay on Abbott Architect i1000SR platform
PROCEDURE: HE4 assay on Architect i1000SR platform
PROCEDURE: Transvaginal Ultrasound

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]